Since, until now, PD-1 antibodies are not usually included in most B-ALL marker and diagnostic panels, further prospective studies in a larger dataset of B-ALL cases are needed to confirm the findings linking leukemia cell genomics and PD-1 expression. The gene discussed is PDCD1; the disease is leukemia.